OT VERIO2 METER
Report
- Report Number
- 2939301-2015-36510
- Date Received
- August 29, 2015
- Date of Event
- August 23, 2015
- Report Date
- August 24, 2015
- Manufacturer
- LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
- Product Code
- NBW
- PMA / PMN Number
- K131363
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- PATIENT
Narratives
FOLLOW-UP # 1: THE LAY USER/PATIENTS TEST STRIPS HAVE BEEN RETURNED AND EVALUATED BY LIFESCAN PRODUCT ANALYSIS WITH THE FOLLOWING FINDINGS: THE TEST STRIPS PASSED ALL TESTING WITH NO FAULTS FOUND. THE REPORTED ISSUE COULD NOT BE CONFIRMED. IF LIFESCAN OBTAINS ADDITIONAL INFORMATION REGARDING THIS COMPLAINT, A FOLLOW UP REPORT WILL BE SUBMITTED. AT THIS TIME, LIFESCAN CONSIDERS THIS MATTER CLOSED.
FOLLOW-UP # 2: DEVICE EVALUATION. THE LAY USER/PATIENTS METER HAS BEEN RETURNED AND FURTHER EVALUATED BY LIFESCAN PRODUCT ANALYSIS WITH THE FOLLOWING FINDINGS: THE METER PASSED ALL TESTING WITH NO FAULTS FOUND. THE REPORTED ISSUE COULD NOT BE CONFIRMED. IF LIFESCAN OBTAINS ADDITIONAL INFORMATION REGARDING THIS COMPLAINT, A FOLLOW UP REPORT WILL BE SUBMITTED. AT THIS TIME, LIFESCAN CONSIDERS THIS MATTER CLOSED.
LIFESCAN (LFS) HAS REQUESTED RETURN OF THE SUBJECT PRODUCT(S) FOR EVALUATION. IF THE PRODUCT(S) ARE RETURNED, LFS WILL EVALUATE IT/THEM AND INFORM FDA OF PRODUCT(S) THAT DO NOT PASS INSPECTION IN A SUPPLEMENTAL REPORT.
ON (B)(6) 2015, THE PATIENT CONTACTED LIFESCAN (LFS) (B)(4) ALLEGING THAT THEIR ONETOUCH VERIO 2 METER WAS READING INACCURATELY HIGH COMPARED TO FEELINGS/NORMAL RESULTS. THE COMPLAINT WAS CLASSIFIED BASED ON CUSTOMER SERVICE REPRESENTATIVE (CSR) DOCUMENTATION. THE PATIENT DETAILED THAT THE ALLEGED PRODUCT ISSUE BEGAN ON (B)(6) 2015; 18:00 - 18:30. SHE REPORTED THAT SHE OBTAINED A BLOOD GLUCOSE RESULT OF 177MG/DL ON THE SUBJECT METER WHICH SHE WAS COMPARING TO HISTORIC RESULTS FROM A LOG BOOK WHICH SHE HAD RECORDED WITH A PREVIOUS METER. THE PATIENT MANAGES HER DIABETES BY SELF-ADJUSTING THEIR INSULIN DOSAGE AND REPORTED THAT ON "(B)(6) 2015; 18:00 - 18:" SHE INCREASED HER DOSE OF MEDICATION "7 UNITS OF HUMALOG" AS A RESULT OF THE ALLEGED PRODUCT ISSUE. THE PATIENT STATED THAT "2 -.5 HOURS" FTER THE ALLEGED ISSUE OCCURRED SHE DEVELOPED THE SYMPTOMS OF "SHAKY AND RACING HEART", WHICH SHE SELF-TREATED WITH "LIQUID DEXTROSE." AT THE TIME OF TROUBLESHOOTING THE CSR NOTED THAT THE UNIT OF MEASURE WAS SET CORRECTLY AND THE TEST STRIPS HAD BEEN STORED CORRECTLY AND THE TEST STRIP VIAL WAS NOT CRACKED OR BROKEN. THE PATIENT NO LONGER HAD CONTROL SOLUTION TO CARRY OUT A TEST. REPLACEMENT PRODUCTS WERE SENT TO THE PATIENT. THIS COMPLAINT IS BEING REPORTED BECAUSE THE PATIENT REPORTEDLY SUFFERED SYMPTOMS SUGGESTIVE OF A SERIOUS INJURY AFTER THE ALLEGED PRODUCT ISSUE BEGAN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 573296 | OT VERIO2 METER | GLUCOSE MONITORING SYS/KIT | NBW | LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL | 3783099 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 69 YR | Life Threatening |